The value of contrast-enhanced ultrasound in evaluating the efficacy of targeted therapy and immunotherapy for hepatocellular carcinoma
Specialists' Article|更新时间:2026-03-25
|
The value of contrast-enhanced ultrasound in evaluating the efficacy of targeted therapy and immunotherapy for hepatocellular carcinoma
“Experts from Zhongshan Hospital affiliated with Fudan University analyzed the imaging characteristics of hepatocellular carcinoma after targeted and immunotherapy, and found that the diagnostic accuracy of CEUS reached 100%, providing an effective imaging method for post treatment evaluation of primary liver cancer.”
OncoradiologyVol. 35, Issue 1, Pages: 19-24(2026)
作者机构:
1.复旦大学附属中山医院超声科,上海 200032
2.镇江市第一人民医院超声科,江苏 镇江 212000
作者简介:
基金信息:
General Project of National Natural Science Foundation of China(82272013;82472004)
CHEN Y N, YUAN K, WANG F H, et al. The value of contrast-enhanced ultrasound in evaluating the efficacy of targeted therapy and immunotherapy for hepatocellular carcinoma[J]Citation:. Oncoradiology, 2026, 35(1): 19-24.
CHEN Y N, YUAN K, WANG F H, et al. The value of contrast-enhanced ultrasound in evaluating the efficacy of targeted therapy and immunotherapy for hepatocellular carcinoma[J]Citation:. Oncoradiology, 2026, 35(1): 19-24. DOI: 10.19732/j.cnki.2096-6210.2026.01.003.
The value of contrast-enhanced ultrasound in evaluating the efficacy of targeted therapy and immunotherapy for hepatocellular carcinoma
Nomogram visualization of peritumoral infiltration risk in glioblastoma using fused contrast-enhanced ultrasound and contrast-enhanced MRI
Deep learning-based ultrasound assessment for predicting early recurrence risk after radiofrequency ablation in hepatocellular carcinoma
A comparative analysis of contrast-enhanced ultrasound and contrast-enhanced computed tomography in the diagnosis of liver metastasis from pancreatic cancer
Research advances in contrast-enhanced ultrasound for evaluating the efficacy of non-surgical treatments for liver cancer
Quantitative parameters of contrast-enhanced ultrasound predict the treatment response to combined immunotherapy and targeted therapy for hepatocellular carcinoma
Related Author
HU Xing
XIE Rong
ZHANG Xiandi
WANG Yong
ZHU Yingfeng
DING Hong
ZHANG Yu
SUN Wenqi
Related Institution
Department of Ultrasound Medicine, Huashan Hospital, Fudan University
Department of Neurosurgery, Huashan Hospital, Fudan University
Department of Pathology, Huashan Hospital, Fudan University
The department of Ultrasound, Harbin Medical University Cancer Hospital
Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine